{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:05:32Z","timestamp":1794269132576,"version":"4.9.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY014943"],"award-info":[{"award-number":["EY014943"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ajo.2009.09.026","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T04:07:46Z","timestamp":1262232466000},"page":"423-432.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"title":["Mycophenolate Mofetil for Ocular Inflammation"],"prefix":"10.1016","volume":"149","author":[{"given":"Ebenezer","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth S.","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Oktay","family":"Ka\u00e7maz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2009.09.026_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1442-9071.2003.00704.x","article-title":"Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation","volume":"31","author":"Lau","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","article-title":"Mycophenolate mofetil in the treatment of uveitis in children","volume":"91","author":"Doycheva","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00417-005-0066-8","article-title":"Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis","volume":"244","author":"Siepmann","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2009.09.026_bib6","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1177\/096120330501400111","article-title":"MMF and eye disease","volume":"14","author":"Zierhut","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.ajo.2009.09.026_bib7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.ajo.2009.09.026_bib8","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II INP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2009.09.026_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1196\/annals.1423.055","article-title":"Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability","volume":"1110","author":"Iaccarino","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajo.2009.09.026_bib10","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1097\/01.tp.0000186389.19911.9c","article-title":"Use of mycophenolate mofetil in autoimmune and renal diseases","volume":"80","author":"Appel","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ajo.2009.09.026_bib11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.09.026_bib12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.09.026_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/jop.2006.22.168","article-title":"Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease","volume":"22","author":"Choudhary","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2009.09.026_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2008.03.004","article-title":"Mycophenolate mofetil for the treatment of uveitis","volume":"146","author":"Teoh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.09.026_bib16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.transproceed.2005.02.038","article-title":"Mycophenolate mofetil-induced neutropenia in liver transplantation","volume":"37","author":"Nogueras","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajo.2009.09.026_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ajo.2009.09.026_bib18","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.09.026_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib20","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"1587","article-title":"Adrenocorticotropic hormone; Adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones","author":"Schimmer","year":"2006"},{"key":"10.1016\/j.ajo.2009.09.026_bib21","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","article-title":"Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy","volume":"115","author":"Thorne","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.09.026_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.09.026_bib23","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Risk of overall and cancer mortality among patients with ocular inflammation treated with immunosuppressive therapy: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2009.09.026_bib24","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.09.026_bib25","first-page":"28","article-title":"Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs","volume":"47","author":"Ostensen","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajo.2009.09.026_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2008.04.008","article-title":"Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero","volume":"199","author":"Huang","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajo.2009.09.026_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409007399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409007399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:00:39Z","timestamp":1757595639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939409007399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0002939409007399"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2009.09.026","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate Mofetil for Ocular Inflammation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2009.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}